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Previous studies in animals and humans have implicated the X-
chromosome STS gene in the etiology of attentional difficulties
and attentiondeficit hyperactivity disorder (ADHD).This family
based association study has finemapped a region of the STS gene
across intron 1 and 2 previously associated with ADHD, in an
extended sample of 450 ADHD probands and their parents.
Significant association across this region is demonstrated indi-
vidually with 7 of the 12 genotyped SNPs, as well as an allele
specific haplotype of the 12 SNPs. Theover transmitted risk allele
of rs12861247 was also associated with reduced STS mRNA
expression in normal human post-mortem frontal cortex brain
tissue compared to the non-risk allele (P¼ 0.01). These results
are consistent with the hypothesis arising from previous litera-
ture demonstrating that boys with deletions of the STS gene, and
hence no STS protein are at a significantly increased risk of
developing ADHD. Furthermore, this study has established the
brain tissue transcript of STS, which except from adipose tissue,
differs from that seen in all other tissues investigated.
 2010 Wiley-Liss, Inc.
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INTRODUCTION
Attention deficit hyperactivity disorder (ADHD) is one of the
most heritable and prevalent childhood psychiatric disorders
[Asherson, 2004], affecting an estimated 5% of school-aged chil-
dren [Polanczyk et al., 2007]. Like most other neurobehavioral
disorders, ADHD presents with a male bias [Swanson et al., 1998],
which supports a possible role for X-linked genes in the etiology.
Recent work from both human and animal studies suggests the
X-linked gene; steroid sulfatase (STS) may have a role in attention.
Boys with X-linked ichthyosis, who have a deletion or point
mutation of STS are at an increased risk of ADHD [Kent et al.,
2008] and common variants within the STS gene may increase
susceptibility to ADHD [Brookes et al., 2008]. Both pharmacologi-
cal manipulation of the steroid sulfatase axis and haplo-insuffi-
ciency of the STS gene have been shown to affect components
of attentional functioning in mice [Davies et al., 2007, 2009]. STS,
which escapes X inactivation in humans, desulfates several sulfated
steroids including sulfated dehydroepiandrosterone, known as
DHEA-S to DHEA. Both are neurosteroids with effects on several
neurophysiological and behavioral processes including some evi-
dence for an inverse relationship between DHEA blood levels and
clinical symptomatology in boys with ADHD [Strous et al., 2001].
Additionally, methylphenidate, the commonest treatment for
ADHD, has been shown to produce significant clinical improve-
ment in boys with ADHD and simultaneous increases in serum
levels of DHEA-S and DHEA, suggesting that these neurosteroids
may play a role in the therapeutic effects of methylphenidate
[Maayan et al., 2003].
We previously genotyped tagging SNPs (which capture the
majority of diversity of genetic variation across a region) across
the STS gene, with an evidence of association around intron 1 and 2
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[Brookes et al., 2008]. This follow-up study, in an extended
association sample has attempted to narrow down this region of
association by genotyping more SNPs across intron 1 and 2. STS is
known to have at least nine alternate first exons, with at least eight
tissue specific transcripts [Dalla Valle et al., 2007; Zaichuk et al.,
2007;Nardi et al., 2009], although brain tissue has not yet been fully
investigated. We have investigated cDNA from human post-mor-
tem brain tissue to establish the brain tissue transcript for STS
and have investigated possible functional roles of associated SNPs
through investigation of STS mRNA levels.
MATERIALS AND METHODS
In this study, 450 probands and their parents were genotyped for
12 fine mapping STS SNPs. Eight of these SNPs had not been
genotyped inourprevious studyof 383probandswhile fourof these
SNPs (rs5934740, rs7058445, rs2270112, and rs12861247) had been
previously genotyped in 383 of the 450 probands [Brookes et al.,
2008].Therefore thedata for eight SNPs inall 450probands isnovel,
and the data for the four previously genotyped SNPs is new for the
additional 67 probands only.
Association Sample
For this study 450 ADHD probands (inclusive of 12 affected
siblings) and their parents were recruited from several child
psychiatry clinics in the UK (N¼ 183) and Ireland (N¼ 267),
following approval from the appropriate research ethics commit-
tees. Parental DNA was available for 98% of mothers and 68% of
fathers. After complete description of the study to the subjects,
written informed consent was obtained. For 380 of the probands
from the UK and Ireland, parents were interviewed by trained
psychiatrists or psychologists employing the Child and Adolescent
Psychiatric Assessment (CAPA) [Angold et al., 1995]. Consistent
interview procedures were employed across the two centers with
researchers from each center receiving a common training in the
use of the CAPA. Inter-rater reliability kappa coefficients were
calculated for ADHD subtype diagnoses (k¼ 0.82; CI¼ 0.71–0.94).
The remaining 70 UK probands were interviewed with the parent
version of the K-SADS interview [Kaufman et al., 1997] by a trained
psychologist. Consistent interview procedures were employed
across the two centers with researchers from each center receiving
a common training in the use of the CAPA. Inter-rater reliability
kappa coefficients were calculated for ADHD subtype diagnoses
(k¼0.82; CI¼ 0.71–0.94). In addition, teacher ratings were ob-
tained for children by the Conners Teacher Rating Scale (CTRS)
[Conners, 1998]. This was to confirm that symptoms met the
criterion of pervasiveness. Established cut-off points for possible
and likelyADHDcaseness on theCTRSwere adhered to, that is, aT-
score above 55 which was required. All 450 probands were White
and born in the UK or Ireland (Age range 4–16 years). The sample
was predominantly male (90.1%) with no significant difference in
sex ratio between the two study recruitment centers. All probands
fulfilled DSM-IV diagnostic criteria for ADHD. Of these N¼ 42
(9.3%) had the inattentive subtype, and N¼ 38 (8.4%) had the
hyperactive impulsive subtype, the rest had combined subtype
(82.3%). Children with an IQ below 70, autistic spectrum disorder
or significant medical conditions such as epilepsy were excluded.
Two-hundred eleven children (46.9%) had comorbid oppositional
defiant disorder and 69 children (15.3%) fulfilled criteria for
comorbid conduct disorder. Frequencies of subtype and comor-
bidity were similar across the two recruitment centers.
Human Post-Mortem Brain Sample
Twenty-one (all male) samples of human post-mortem frontal
cortex were obtained from the Medical Research Council (MRC)
Sudden Death Brain and Tissue Bank, Edinburgh prior to this
study. Deceased individuals were aged 16–70 years (mean¼
46.3 years). RNA quality was measured by optical density (OD)
with a Bioanalyzer (Agilent, CA). Sample OD260/OD280 ratios
ranged from 1.5 to 2.0. Mean brain pH was 6.3 (SD¼ 0.25). The
samples were crushed and stored at80C for future use. RNA and
DNA extraction was carried out using the MELT Total Nucleic
Acid IsolationSystem(AppliedBiosystem, FosterCity, CA, 1983)
and concentrations determined using aNanoVue (GEHealth Care,
UK). The cDNA was created with reverse transcriptase-mediated
polymerase chain reaction (RT-PCR) using the AffinityScript
QPCR cDNA Synthesis Kit (Stratagene, CA) on the Mx3005P
machine (Stratagene).
Association Study and Brain sample Genotyping
For association study samples, high molecular weight genomic
DNAwas extracted fromwholeblood, cheek swaborOragene saliva
collection systems (DNA Genotek, Ontario, Canada) according to
routine procedures. Brain issue DNA was extracted as above.
Fine mapping SNPs for STS were selected from Hapmap based on
heterozygosity and linkage disequilibriumparameters and rs1473666
in exon 0b was identified as described below. SNP genotyping assays
were obtained from Applied Biosystems for use on the Stratagene
Mx3005P real-time PCRmachine (Stratagene) following standard-
ized protocols provided with the assays.
Alternative First Exon Genotyping
The sequences of the recently documented six alternate first exons
of STSdesignated 0a, 0b, 0c, 1a (exon 1a, 216 base pairs in size, is the
previously known exon 1 of STS), 1b, 1c, and 1d byDalla Valle et al.
[2007], were compared to the human genome sequence using
BLAST (http://blast.ncbi.nlm.nih.gov) to determine genomic
location. Figure 4 demonstrates their relative positions. Exons 0a
(351 bp) and 0b (77 bp) are in the 50 region of the upstream gene,
5HDHD1A, which is transcribed from the reverse strand, exon
0c (341 bp) is intragenic between 5HDHD1A and STS, exon 1b
(129 bp) is in the 50 region of STS and exons 1c (98 bp) and 1d
(246 bp) arewithin intron1of theSTS gene. TwoSNPs fromdbSNP
were identified, currently labeled as intronic, but which lie in these
alternate first exons: both rs12839420 and rs1473666 reside in exon
0b but only rs1473666 was polymorphic.
Amplification of cDNA to establish the presence/absence of
alternative first exons in the STS human brain transcript was
performed on 21male and 7 female post-mortem brain samples.
Primer pair amplifications were combined into two multiplex and
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two single plex reactions. Each PCR contained a positive control
primer set for detecting cDNA in the known coding region of the
STS gene, and a negative control pair set which detected intronic
DNA (see Supplementary Table I). GenomicDNAwas amplified in
each reaction as a positive control for the presence of all alternative
exons. cDNA samples were run in triplicate. Standard PCR con-
ditions were employed and PCR products were visualized on a 2%
agarose gel.
DNA Sequencing
Mutation detection of STS exon 2 and the alternate exon 1’s present
in the brain transcript was performed by sequencing genomic DNA
from 150 (for exon 2) and 100 (for exons 0a and 1b) male ADHD
probands and 96 male controls obtained from Human Random
Control DNA panels (HRC-1 and -2; European Collection of Cell
Cultures, Sigma–Aldrich, Salisbury, UK). For exon 0a a product
of 556 bp was obtained using primers (50GCAGCTGTTCTCAAA-
CGTTCACGC30) and (50GGCTCCGCGTCCTCTCCTCA30); for
exon 1b a product of 617 bp was obtained with primers
(50GGGTTGGGAACCCCTG CTGC30) and (50ACATGGTCT-
GGGTGAGTCAAACACT30); for exon 2 a product of 713 bp was
obtained using primers located within intron 1 (50AGGCTGTT-
GACCCCATACAC30) and intron 2 (50GTGTCATGAAGGCAGG-
TGTG30) and amplified using standard conditions and thermal
cycles. Sequence was compared to genomic DNA NCBI ref
sequence (NC_000023.10) using CodonCode Aligner version 3
(CodonCode Corporation) to identify novel polymorphisms.
cDNA PCR products from eight male human brain tissue
samples covering the entire possible transcript from exon 0a
in 5HDHD1a through to the end of the 30UTR of STS was also
sequenced with 13 overlapping sequencing reactions. This was to
confirm the agarose gel findings indicating the presence or absence
of eachalternatefirst exon in thebrain transcript and to establish the
entire transcript for STS in brain tissue. The forward primer of exon
0a combinedwith the reverse of exon 1b; and the forward primer of
1b and reverse primer of exon 2 were used for sequencing of the
upstream region of the STS gene (see Supplementary Table I for
sequences). Primer pairs (Supplementary Table II) were designed
and used to sequence the rest of the coding sequence and tran-
scribed 30UTR sequences present in the mRNA. Standard PCR
conditions were employed. All sequencing was performed com-
mercially using anApplied Biosystems 3730DNA sequencer by The
Sequencing Service,University ofDundee. Sequencewas compared
to genomic DNA NCBI ref sequence (NC_000023.10) using Co-
donCode Aligner version 3 (CodonCode Corporation) to deduce
transcribed regions in the brain transcripts.
mRNA Expression
The STS primers and probe sequences were acquired from
Applied Biosystems. The probe was FAM labeled and designed
based on sequences spanning across exons 4 and 5 of the gene
(Hs00996676_m1). Endogenous control gene assays used were
human GAPDH and b-Actin (Applied Biosystems). Quantitative
PCR was performed in triplicate for each sample on a Stratagene
MX5003Pusing a standardprotocol. The expressiondata produced
were analyzed and converted into threshold cycle values (Ct values)
using the software program MXPro Version 4.0 (Stratagene).
Statistical Analyses
For the association studies, TDT analysis for each sample was
carried out using the program software UNPHASED, which in-
cludes subjectswithmissing parental genotypes [Dudbridge, 2008].
In the current analysis a flag indicating the presence of an X-linked
gene was included, therefore only maternal transmissions were
counted. In addition, the UNPHASED program allows for permu-
tations of the data, which allows some correction for multiple
testing. Linkage disequilibrium across the SNPs and haplotype
analysis were performed in Haploview [Barrett et al., 2005].
For the mRNA expression studies, mean values were obtained
from the triplicate Ct values for each probe per sample. The target
STS mRNA expression was normalized to two endogenous refer-
ence genes (GAPDH and b-Actin) to generate a DCt value. The
relationship between the DCt values (STS mRNA expression)
and the different genotype groups were analyzed by t-test in the
analytical program SPSS Data Editor Version 17.0. In order to
analyze both housekeeping genes together, geNORM software
[Vandesompele et al., 2002] was used to create a gene expression
normalization factor which is calculated for each sample based on
the geometric mean of the housekeeping reference genes.
RESULTS
SNP Marker Association Study
Hardy–Weinberg equilibrium, calculated with allele frequencies
from females only, was observed for all SNPs. Allele frequencies and
genotype frequencies were similar between the two sites. Results
are shown in Table I. Four tagging SNPs from the original study
[Brookes et al., 2008] were also genotyped in this extended sample:
rs5934740, rs7058445, rs2270112, and rs12861247. Of these,
rs2270112 and rs12861247, which were significantly associated in
the original study, were found to maintain significant association
with ADHD in the extended dataset with similar odds ratios as the
original study (rs2270112 OR was 1.48; rs12861247 was 2.05). Of
the eight SNPs not previously genotyped, five SNPs residing in the
first two introns also demonstrated significant association with
ADHD. In the first intron of the STS gene three SNPs displayed
significant association with ADHD: rs6639786 (P¼ 0.01), rs5934769
(P¼ 0.02), rs5934770 (P¼ 0.02). Within intron 2, one SNP indi-
cated evidence of an association, rs1733558 (P¼ 0.01). In addition,
rs1473666 in the 0b alternative exon also yielded a significant result
(P¼ 0.05). All D0 linkage disequilibrium values are shown in
Figure 1 which demonstrates one haploype block with low recom-
bination. The application of the stringent multiple testing Bonfer-
roni correction resulted in none of the SNP markers preserving
statistical significance for association. An overall gene-wide signifi-
cant test by permutation analysis (1,000 permutations) suggested a
weak trend towards significance (P¼ 0.09).
Of all possible haplotypes, seven had at least a 1% frequency. There
was significant over-transmission of one allele specific haplotype:
CGGTTCTGCTGG (haplotype frequency¼ 0.23, c2¼ 10.13, P¼
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0.02), which consisted of all the significantly over-transmitted
alleles for individual SNPs. This did not survive Bonferroni cor-
rection for the seven allele specific haplotypes tested.
The analysis was re-run excluding female probands (N¼ 47)
to investigate the association in males. The markers rs12861247
(P¼ 0.02) and rs17335568 (P¼ 0.04) in intron 2 remained signifi-
cantly associated andLDpatterns across the region that didnot alter
substantially (see Supplementary Fig. 1 for LD plot of male only
sample). It might be expected that ADHD females would have
greater than expected homozygous rates for the significant risk
alleles seen in hemizygous males. Therefore, the frequency of
homozygote females for the risk alleles that were associated in the
entire sample were compared to that estimated from the allele
frequencies provided by HapMap or dbSNP. The sample was
found to have a higher frequency of homozygous females for the
risk G-allele of the marker rs5934770 than expected from estima-
tions from dbSNP data (89% vs. 72%; P¼ 0.002). A trend for a
higher frequency of females homozygous for the risk G-allele of
rs12861247 (P¼ 0.06) was also observed. Neither of the SNPs
associated with the male only analysis had significantly higher than
expected risk allele homozygotes in the females.
Alternate First Exon Usage in Brain Transcript
Figures 2 and 3 demonstrate all alternative first exons present in the
cDNA with the negative control for mRNA (the amplification of
intron2 sequencewhich should only bepresent in genomic) and the
positive control for mRNA (the sequence spanning exons 3–5
which is too large to resolve from genomic) in Figure 2. Within
the brain STS transcript exons 0a, 1b, and 2 are the most abundant
TABLE I. Allele frequencies and TDT analysis result
SNP Location HWE Genotyped MAF
Informative
trios P-value T NT OR 95% CI
Over-transmitted
allele
rs1473666 Exon 0b 0.81 95.7 0.455 236 0.05 101 86 1.17 0.92–2.06 C
rs1000900 Intron 1 0.20 98.9 0.273 265 0.7 89 78 1.14 0.85–2.00 G
rs5934740 Intron1 0.78 91.5 0.461 211 0.33 87 81 1.07 0.75–1.77 G
rs6639786 Intron1 0.92 96.7 0.436 246 0.01 103 82 1.26 1.05–2.36 T
rs11095437 Intron1 0.05 99.1 0.233 266 0.36 85 69 1.23 0.97–2.36 T
rs2024159 Intron1 0.56 97.9 0.264 255 1 81 75 1.08 0.75–1.82 C
rs5934769 Intron1 0.13 86.9 0.423 224 0.03 83 69 1.20 0.92–2.26 T
rs5934770 Intron1 0.10 99.3 0.155 269 0.02 50 40 1.25 0.87–2.79 G
rs2270112 Intron 1 0.27 97.3 0.27 252 0.03 76 58 1.31 1.06–2.75 C
rs7058445 Intron 2 0.51 91.7 0.281 241 0.68 75 66 1.14 0.86–2.16 T
rs12861247 Intron 2 0.47 97.1 0.103 253 0.01 49 26 1.88 1.79–6.40 G
rs17335568 Intron 2 0.78 98.7 0.446 264 0.01 112 88 1.27 1.09–2.39 G
HWE, Hardy–Weinberg equilibrium; MAF, minor allele frequency; T, transmitted; NT, non-transmitted; OR, odds ratio; 95% CI, 95% confidence intervals.
FIG. 1. D0 linkage disequilibrium between STS SNPs.
FIG. 2. PCR results for the presence in brain tissue of alternative
exons 0c, 1a, 1c, and 2.
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exons present, with no apparent detection of exons 0b, 0c, 1a
(exon1), 1c, 1d, and 1e. Exon 0d was too small to amplify
(17 bp) but was not present in the DNA sequencing (see below).
DNA Sequencing
Sequencing of exon 0a, 1b, exon 2 in genomic DNA of 150 male
ADHD probands and 96 male controls revealed no new poly-
morphisms. Sequencing of the STS gene cDNA, created from RNA
isolated from 8 of the 21 post-mortem brain samples confirmed the
inclusion of the alternative exons 0a and 1b [as described by Dalla
Valle et al., 2007] and exon 2 in the transcript (schematic in Fig. 4).
Nonewpolymorphismsweredetected in the coding sequenceor the
UTRs present in the transcript. From exon 2 downstream, the
transcript was identical toNCBI reference sequence (NM_000351).
STS mRNA Expression
Gene expression of the STS gene in human post-mortem frontal
cortex samples was approximated by the measurement of mRNA
levels via quantitative PCR. Expression data in relation to the seven
SNPmarkers that were observed to show statistical significance for
association with ADHD were analyzed. Relative STS mRNA ex-
pression levelswere normally distributed byKolmogorov–Smirnov
tests, and co-factors such as post-mortem interval, age, sex, and pH
were not correlatedwith STSmRNAorprotein expression level and
therefore not included as covariates. There were no batch effects for
different Quantitative-PCR runs. A significant relationship be-
tween the G-allele of rs12861247 and lower STSmRNA expression
relative to GAPDH was noted (t¼2.76, P¼ 0.01; Fig. 5). This
does not survive Bonferroni correction for the seven SNPs tested.
No associations with STS mRNA expression were evident for any
SNP when both housekeeping genes were analyzed together using
GeNORM (see Supplementary Fig. 2).
DISCUSSION
In this study,wehavedemonstrated further evidence for association
of the STS gene with ADHD. This study focussed on findings from
previous work [Brookes et al., 2008] by initially fine mapping
a region spanning intron 1 and 2. Novel findings for five SNPs in
this region were found with significant evidence for association:
rs6639786, rs5934769, rs5934770 located within intron 1;
rs17335568 located within intron 2; and rs1473666 in the alternate
exon (0b) locatedupstream in the50 regionof5HD1A1A. Twoof the
previously genotyped SNPs, rs2270112 and rs12861247 were also
still significant in this larger sample. However, none survived
stringent correction for multiple testing and 1,000 permutations
of the data provided a trend for significance only. Linkage disequi-
librium between the individual SNPs is very high with all the new
associations in this study being in high LD with the four SNPs
significantly associated in our previous study [Brookes et al., 2008].
FIG. 3. PCR results for the presence in brain tissue of alternative exons 0a, 0b, 1b, 1d, and 1e.
FIG. 4. Schematic diagrams showing alternate first exons present in brain transcript mRNA in relation to genomic DNA.
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At this stage it is therefore difficult to determine which SNP, or
SNPs are responsible for the significant association, and which
appear significant by virtue of LD with other SNPs. Further studies
todeterminewhichSNPshave functional effects on gene expression
and ondownstream targets such as STS activity andDHEA /DHEA-S
levels may provide some indirect evidence for which SNP/s are
relevant.
Of the seven significantly associated SNPs, risk alleles for four
(rs5934770, rs2270112, rs12861247, rs17335568) are predicted to
create new transcription factor binding sites (http://www.cbrc.jp/
research/db/TFSEARCH.html). It is well established that transcrip-
tional regulatory elements can be located within introns, particu-
larly intron 1 [e.g., Surinya et al., 1998; Gemel et al., 1999; Ozaki
et al., 2002]. Several binding sites in the Rel/NFKappa transcription
factor family are created by the risk allele for rs17335568 and a
upstream transcription factor 1 binding site for the risk allele of
rs5934770, a transcription factor involved in lipid and glucose
homeostasis, although it is not immediately apparent how these
particular binding sites might be involved in ADHD pathophysiol-
ogy. Of more interest is the POU3F1/Tst-1/Oct 6 binding site,
predicted tobe abolishedby the risk allele of rs12861247,whichmay
impact onmRNA expression. POU3F1 is amember of the POU-III
family of homeodomain proteins, whose primary role is thought
to be developmental. It is expressed in cells of the oligodendrocyte
lineage [Collarini et al., 1992;Wegner, 2001] andFrantz et al. [1994]
suggested it also played a role in regulating transcription in differ-
entiated CNS neurons as well as in proliferating glial precursors.
Of particular interest is the finding that affected females, com-
pared to Hapmap or dbSNP allele frequencies were statistically
more likely to be homozygous for the G-risk allele of rs5934770 and
showed a trend formore homozygotes for the G-allele of rs12861247.
In our previous study [Brookes et al., 2008], we found statistically
more homozygote females for theG-allele of rs12861247 andhypoth-
esizedamodelwhereby femaleswouldneed tobehomozygote forSTS
gene risk alleles in order to increase their susceptibility to ADHD.
These two SNPs located in intron 1 and 2, respectively have high
linkage disequilibrium between them (D0 ¼ 0.92) and may not be
independent findings. They may also be ‘‘tagging’’ another poly-
morphism, but if so, this is unlikely to be a commonpolymorphism
in exon 2 as sequencing in 150 ADHD male probands and nearly
100 controls did not reveal any new mutations. Therefore, further
investigation of the association findings were focussed upstream of
exon 2.
Tissue specificity of STS transcripts has been recently reported
[Dalla Valle et al., 2007; Zaichuk et al., 2007; Nardi et al., 2009],
although brain tissue specificity has not been widely investigated.
The presence or absence of each of the possible seven alternate
first exons originally described by Dalla Valle et al. [2007] was
investigated by RT-PCR in human post-mortem brain tissue using
individual primer pairs for each exon and confirmed by sequencing
of the entire transcript. PCR products could be amplified in the
brain transcript for exons 0a, 1b, and 2.This is identical to one of the
two tissue specific transcript for adipose tissue identified by Dalla
Valle et al. [2006]. This transcript does not appear to contain exon
1a, otherwise known as exon 1, which is in the placental transcript.
Zaichuk et al. [2007]demonstrated that transcripts containing exon
1b were by far the most abundant in brain tissue (6,107 amol/mg)
but they also detected minute amounts of exons 1a (7.6 amol/mg)
and 1c (2.0 amol/mg), but at such small levels of detection these
could arguably be as a result of measurement error. It is possible
that other exons are present in brain tissue but as RT-PCR will
favor amplification of the most abundant transcript, the quantity
produced may not have been detectable by our methods.
Exon 1b is highly homologous to several non-human primate
STS mRNAs, suggesting a preserved functional role. It contains a
putative ATG start site, with a stronger Kozac consensus sequence
than the in frame ATG start site in exon 2. Use of the exon 1b
start site would result in a transcript 12 amino acids longer at theN-
terminal than that produced from the exon 2 start site, and seven
amino acids longer than that produced in placental tissue that
uses the exon1(exon1a) start site. Signal peptideprediction (http://
www.cbs.dtu.dk/services/SignalP/) suggests that this difference has
no impact on the signal peptide cleavage site. The presence of exon
0a upstream of exon 1b in the brain transcript is a novel finding in
this study although this exon is not translated [Dalla Valle et al.,
2007;Nardi et al., 2009].Additionally, although there is a significant
association of rs1473666 in the alternate exon 0bwith ADHD this is
more likely to be as a result of this variant being in LDwith another
significantly associated marker, than a true functional variant, as
this exondoes not appear tobepresent in the brain transcript, and is
not translated in tissue transcripts that do contain it [Dalla Valle
et al., 2006; Nardi et al., 2009]. Given the presence of exon 0a and 1b
in the brain transcript, we also sequenced genomic DNA for these
exons in 150ADHDmale probands and nearly 100 controls but did
not discover any new polymorphisms.
Levels of STS mRNA were also investigated in human post-
mortem brain tissue in relation to genotype. We hypothesized that
because boys with STS deletions, and therefore no detectable STS
protein, havehigher than expected rates of inattentiveADHD, some
boys with ADHD would be predicted to have lower levels of STS
mRNA. Although the G-allele of rs12861247, which was signifi-
FIG. 5. Relative STS expression compared to GAPDH for
rs12861247. Higher values correspond to lower STS mRNA
levels. Error bars represent 95% CI.
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cantly associatedwithADHD,was also significantly associatedwith
a lower STSmRNA level relative to the GAPDH control gene, using
an alternative method of analysis, withmore than one house keeping
gene control, did not support this initial finding. However, brain
tissue is composed of a variety of cell types such that mRNA
expression levels of genes may vary between samples as a result of
differences in cell composition of the particular piece of tissue used.
These findings for STS mRNA expression levels in relation to
genotype in brain tissue therefore require further investigation,
preferably using a more cell specific approach such as laser capture
micro-dissection techniques. The use of post-mortem brain tissue
still has several advantages over in vitro techniques. The endoge-
nous promoters and all other gene sequences, etc. needed for gene
regulation are present in the tissue and this arguably provides a
more relevant paradigm than cell lines and reporter vector systems,
which do not represent normal tissue. However, Additionally, the
tissue employed for this study was from ‘‘normal’’ individuals with
no known history of psychiatric disorder (although this cannot be
ruled out) and the sample size was small, and possibly limited in
power to detect what are likely to be small effect sizes of these SNPs.
Additionally, the small sample size may not allow the detection of
rare brain transcripts that use exons 1a and 1c as suggested by
Zaichuk et al. [2007].
In summary, this association study provides further evidence
that genetic variation in the STS SNPs (rs1286124 gene may be
implicated in ADHD susceptibility. One of the significantly associ-
ated 7) in intron 2 may be associated with lower STS mRNA
expression as well as being more prevalent in female ADHD
homozygotes. Replication of these findings is needed as well as
further functional investigation of the associated alleles.
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